Showing 241 - 260 results of 319 for search '"Organ transplant"', query time: 0.07s Refine Results
  1. 241

    Current Bioengineering Methods for Whole Kidney Regeneration by Shuichiro Yamanaka, Takashi Yokoo

    Published 2015-01-01
    “…Here, we review recent advances in the field of kidney regeneration, including (i) the directed differentiation of induced pluripotent stem cells/embryonic stem cells into kidney cells; (ii) blastocyst decomplementation; (iii) use of a decellularized cadaveric scaffold; (iv) embryonic organ transplantation; and (v) use of a nephrogenic niche for growing xenoembryos for de novo kidney regeneration from stem cells. …”
    Get full text
    Article
  2. 242

    Resolved Hepatitis B: Achieved or Imaginary Wellbeing? by S. N. Batskikh

    Published 2021-04-01
    “…Possible virus persistence in the PHB patient's hepatocytes potentiates the agent transmission risk via haemotransfusion, organ transplantation and haemodialysis. Occult HBV infection in PHB individuals can reactivate at background immunosuppressive or chemotherapies. …”
    Get full text
    Article
  3. 243
  4. 244
  5. 245

    Targeting T helper 17 cells: emerging strategies for overcoming transplant rejection by Young Joon Lee, Mi-La Cho

    Published 2024-12-01
    “…Solid organ transplantation has significantly improved the survival rate of patients with terminal organ failure. …”
    Get full text
    Article
  6. 246

    Fatal Case of Probable Invasive Aspergillosis after Five Years of Heart Transplant: A Case Report and Review of the Literature by Toufik Mahfood Haddad, Mahesh Anantha Narayanan, Krista E. Shaw, Renuga Vivekanandan

    Published 2015-01-01
    “…Invasive fungal infections are very common in solid organ transplants and occur most frequently in the first three months after transplant. …”
    Get full text
    Article
  7. 247

    Two Cases of Human T-Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis Caused by Living-Donor Renal Transplantation by Yasutaka Tajima, Mariko Matsumura, Hiroaki Yaguchi, Yasunori Mito

    Published 2016-01-01
    “…In rare instances, recipients of organ transplants from human T-lymphotropic virus type I- (HTLV-I-) positive donors reportedly developed neurologic symptoms due to HTLV-I-associated myelopathy (HAM). …”
    Get full text
    Article
  8. 248

    Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury by Pascal Rowart, Pauline Erpicum, Olivier Detry, Laurent Weekers, Céline Grégoire, Chantal Lechanteur, Alexandra Briquet, Yves Beguin, Jean-Marie Krzesinski, François Jouret

    Published 2015-01-01
    “…Particularly, the duration of blood supply deprivation has been recognized as a critical factor in stroke, hemorrhagic shock, or myocardial infarction, as well as in solid organ transplantation (SOT). Pathophysiologically, IRI causes multiple cellular and tissular metabolic and architectural changes. …”
    Get full text
    Article
  9. 249
  10. 250

    Herpes simplex virus-2-associated esophagitis in immunocompetent host by Haider A. Naqvi, Sumanthkumar Bandaru, Adrien L. Janvier, Muhammad Nadeem Yousaf

    Published 2021-01-01
    “…Common risk factors for HE include a history of HIV, AIDS, malignancy, solid organs transplant, use of steroids, immunosuppressant medications, chemotherapy, and radiation therapy [1, 3–7]. …”
    Get full text
    Article
  11. 251

    Implications for the diagnosis of aspiration and aspergillosis in critically ill patients with detection of galactomannan in broncho-alveolar lavage fluids by Simon Dubler, Michael Etringer, Christoph Lichtenstern, Thorsten Brenner, Stefan Zimmermann, Paul Schnitzler, Bettina Budeus, Fabian Rengier, Paulina Kalinowska, Yuan Lih Hoo, Markus A. Weigand

    Published 2025-01-01
    “…Patients with pIPA had higher disease severity than those with aspiration, including higher dialysis rates, organ transplantation, corticosteroid use, and Sequential Organ Failure Assessment (SOFA) score. …”
    Get full text
    Article
  12. 252

    A General Overview of Mesenchymal Stem Cell Therapies in Drug- and Chemical-Induced Liver Injury Models by Müşerref Şeyma Ceyhan, Suna Ömeroğlu, Zeynep Yığman

    Published 2024-04-01
    “…Because of the limitations of liver transplantation, therapy methods alternative to organ transplantation still need to be studied. Owing to their differentiation and regeneration abilities, mesenchymal stem cells (MSCs) have recently drawn attention as potential therapeutic agents. …”
    Get full text
    Article
  13. 253

    Immune Modulation as Adjunctive Therapy for Pneumocystis pneumonia by Jing Wang, Terry W. Wright, Francis Gigliotti

    Published 2011-01-01
    “…Pneumocystis is an opportunistic fungal respiratory pathogen that causes life-threatening pneumonia (Pcp) in patients suffering from defects in cell-mediated immunity, including those with acquired immunodeficiency syndrome (AIDS) and immunosuppression secondary to chemotherapy or organ transplantation. Despite major advances in health care, the mortality associated with Pcp has changed little over the past 25  years. …”
    Get full text
    Article
  14. 254

    Liver Transplant From a Deceased Donor With Cystinosis: A Case Report by Raeda Taj, Kim Ng, Sanmati R. Cuddapah, Elizabeth B. Rand, Melissa Bleicher, Sandra Amaral, Maarouf A. Hoteit, Rajendar K. Reddy, Eyob Feyssa, Emma E. Furth, Kim M. Olthoff, Samir Abu‐Gazala, Matthew H. Levine, Frederick Vyas, Peter L. Abt

    Published 2025-01-01
    “…ABSTRACT Many inherited metabolic disorders (IMD) are associated with end‐organ damage necessitating organ transplantation. Although utilization of deceased donors with history of IMD warrants caution, there may be circumstances under which such donors could be considered as suitable organ donor candidates. …”
    Get full text
    Article
  15. 255

    Fibrin Gel as an Injectable Biodegradable Scaffold and Cell Carrier for Tissue Engineering by Yuting Li, Hao Meng, Yuan Liu, Bruce P. Lee

    Published 2015-01-01
    “…Due to the increasing needs for organ transplantation and a universal shortage of donated tissues, tissue engineering emerges as a useful approach to engineer functional tissues. …”
    Get full text
    Article
  16. 256
  17. 257

    Primary Hyperoxaluria Type 1 in 18 Children: Genotyping and Outcome by Mohamed S. Al Riyami, Badria Al Ghaithi, Nadia Al Hashmi, Naifain Al Kalbani

    Published 2015-01-01
    “…Fifty percent of the children underwent hemodialysis. 28% of children underwent organ transplantation. The most common mutation found in Omani children was c.33-34insC mutation in the AGXT gene. …”
    Get full text
    Article
  18. 258

    PTLD Burkitt Lymphoma in a Patient with Remote Lymphomatoid Granulomatosis by A. Stravodimou, A. Cairoli, T. Rausch, R. Du Pasquier, P. Michel

    Published 2012-01-01
    “…Posttransplant lymphoproliferative disorder (PTLD) is a potentially fatal complication of solid organ transplantation. The majority of PTLD is of B-cell origin, and 90% are associated with the Epstein-Barr virus (EBV). …”
    Get full text
    Article
  19. 259

    Graft-versus-Host Disease after Living-Unrelated Kidney Transplantation by N. Zacharias, M. H. Gallichio, D. J. Conti

    Published 2014-01-01
    “…Graft-versus-host disease (GVHD) is a rare complication after solid organ transplantation and consists of a reaction of donor derived immune cells directed against host tissues. …”
    Get full text
    Article
  20. 260

    Post-COVID Mucormycosis: An Emerging Threat in Developing Countries - A Prospective Review by Debpratim Chakraborty, Sudipa Adhikary

    Published 2024-11-01
    “…COVID-19 patients with underlying conditions such as diabetes, cancer, or organ transplants are particularly susceptible to mucormycosis due to their immunocompromised state. …”
    Get full text
    Article